Adaptive licensing — A way forward in the approval process of new therapeutic agents in Europe
Clinical Trials and Regulatory Science in Cardiology · 2015
DOI: 10.1016/j.ctrsc.2015.02.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Trials and Regulatory Science in Cardiology, 2015. Verfasst von Giuseppe M.C. Rosano und 3 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rosano, G. M., Anker, S. D., Marrocco, W., & Coats, A. J. (2015). Adaptive licensing — A way forward in the approval process of new therapeutic agents in Europe. Clinical Trials and Regulatory Science in Cardiology. https://doi.org/10.1016/j.ctrsc.2015.02.001
Vancouver
Rosano GM, Anker SD, Marrocco W, Coats AJ. Adaptive licensing — A way forward in the approval process of new therapeutic agents in Europe. Clinical Trials and Regulatory Science in Cardiology. 2015. doi:10.1016/j.ctrsc.2015.02.001
BibTeX
@article{Rosano2015,
author = {Rosano, Giuseppe M.C. and Anker, Stefan D. and Marrocco, Walter and Coats, Andrew J.S.},
title = {Adaptive licensing — A way forward in the approval process of new therapeutic agents in Europe},
journal = {Clinical Trials and Regulatory Science in Cardiology},
year = {2015},
doi = {10.1016/j.ctrsc.2015.02.001}
}
EUVIMED